Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 04:00PM ET
2.66
Dollar change
-0.03
Percentage change
-1.12
%
Index- P/E- EPS (ttm)-5.74 Insider Own1.31% Shs Outstand6.66M Perf Week-3.97%
Market Cap17.72M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float6.58M Perf Month-3.80%
Income-38.22M PEG- EPS next Q- Inst Own40.60% Short Float0.09% Perf Quarter-12.21%
Sales0.00M P/S- EPS this Y- Inst Trans0.12% Short Ratio0.26 Perf Half Y-16.09%
Book/sh3.32 P/B0.80 EPS next Y- ROA-74.26% Short Interest0.01M Perf Year-43.52%
Cash/sh3.56 P/C0.75 EPS next 5Y- ROE-93.69% 52W Range2.30 - 4.82 Perf YTD8.13%
Dividend Est.- P/FCF- EPS past 5Y- ROI-172.94% 52W High-44.81% Beta0.75
Dividend TTM- Quick Ratio10.66 Sales past 5Y115.86% Gross Margin- 52W Low15.65% ATR (14)0.14
Dividend Ex-DateNov 16, 2023 Current Ratio10.66 EPS Y/Y TTM-292.59% Oper. Margin- RSI (14)42.12 Volatility5.37% 4.93%
Employees28 Debt/Eq0.00 Sales Y/Y TTM-100.00% Profit Margin- Recom2.33 Target Price22.67
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q75.80% Payout0.00% Rel Volume0.38 Prev Close2.69
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsFeb 12 AMC Avg Volume22.44K Price2.66
SMA20-4.44% SMA50-1.03% SMA200-9.09% Trades Volume8,591 Change-1.12%
Date Action Analyst Rating Change Price Target Change
Jul-23-24Downgrade Laidlaw Buy → Hold
Mar-25-22Downgrade Wells Fargo Overweight → Equal Weight $13 → $2
Mar-25-22Downgrade Stifel Buy → Hold $6 → $2
Mar-25-22Downgrade Jefferies Buy → Hold $4 → $1
Feb-03-22Initiated Jefferies Buy $4
Sep-22-20Initiated Alliance Global Partners Buy $9
May-29-20Initiated SunTrust Buy $16
Dec-20-18Initiated H.C. Wainwright Buy $10
Dec-20-18Initiated H.C. Wainwright Buy
Jul-27-18Upgrade Stifel Hold → Buy $2.50 → $7
Feb-12-25 04:12PM
Nov-12-24 04:05PM
Sep-19-24 04:01PM
Aug-12-24 08:30AM
Jul-22-24 08:30AM
02:18PM Loading…
Jul-01-24 02:18PM
May-09-24 10:57PM
04:02PM
Apr-11-24 08:02AM
08:00AM
Apr-10-24 08:00AM
Mar-26-24 08:00AM
Mar-09-24 01:09PM
Feb-13-24 06:15PM
05:05PM
06:48AM Loading…
Feb-08-24 06:48AM
Jan-16-24 05:00PM
Dec-11-23 12:00PM
Nov-27-23 10:33AM
Nov-09-23 04:05PM
Nov-08-23 08:00AM
Nov-06-23 04:57PM
Nov-02-23 11:23AM
09:00AM
Nov-01-23 12:03PM
09:00AM
Oct-20-23 11:43AM
Oct-18-23 11:13AM
Oct-17-23 05:33PM
11:47AM
11:30AM Loading…
11:30AM
Oct-16-23 12:53PM
Oct-10-23 10:54AM
Oct-02-23 06:00AM
Sep-29-23 12:00PM
Sep-28-23 05:00PM
Sep-27-23 09:28AM
09:12AM
Sep-26-23 04:02PM
05:03AM
Sep-23-23 05:03AM
Sep-21-23 08:00AM
Sep-18-23 08:00AM
Sep-05-23 12:17PM
Aug-16-23 08:00AM
Jul-26-23 01:47PM
Jul-23-23 02:30PM
Jul-19-23 08:00AM
Jul-18-23 09:00AM
Jul-17-23 09:17AM
08:00AM
Jul-13-23 04:05PM
Jul-11-23 08:00AM
Jul-07-23 08:00AM
Jul-05-23 08:00AM
Jun-29-23 08:00AM
Jun-27-23 05:15PM
09:20AM
Jun-15-23 12:08PM
Jun-13-23 08:00AM
Jun-02-23 08:00AM
Jun-01-23 04:22PM
08:00AM
May-30-23 05:40PM
May-23-23 04:49PM
08:00AM
May-11-23 05:35PM
04:05PM
May-09-23 08:35AM
Apr-18-23 03:31PM
Apr-14-23 04:15PM
Feb-23-23 12:14PM
07:00AM
Feb-17-23 05:12AM
Feb-09-23 06:15PM
04:05PM
Dec-06-22 04:00PM
06:24AM
Dec-05-22 05:01PM
05:00PM
Nov-20-22 07:17AM
Nov-19-22 07:08AM
Nov-18-22 08:00AM
Nov-14-22 05:35PM
04:05PM
Nov-07-22 12:10PM
Nov-03-22 09:00AM
Oct-03-22 04:00PM
Sep-22-22 08:00AM
Sep-08-22 05:00PM
04:05PM
Sep-06-22 08:00AM
Sep-01-22 04:00PM
08:00AM
Aug-18-22 10:35AM
Aug-01-22 04:00PM
Jul-18-22 08:00AM
Jul-01-22 04:00PM
Jun-22-22 08:00AM
Jun-10-22 03:00AM
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.